Login / Signup

Re: Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation.

Jasper H A van MiertKarina Meijer
Published in: Pharmacoepidemiology and drug safety (2019)
Keyphrases
  • atrial fibrillation
  • direct oral anticoagulants
  • oral anticoagulants
  • cardiovascular events
  • venous thromboembolism
  • risk factors
  • cardiovascular disease
  • bone marrow
  • cell therapy